Share

October 2017; 7 (5) Case

Granulomatous meningitis secondary to Avitene (microfibrillar collagen)

Swetha Renati, Supreet Kaur, Jesse L. Kresak, Meredith Wicklund, Irene Malaty
First published September 14, 2016, DOI: https://doi.org/10.1212/CPJ.0000000000000305
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
64

Share

Article Information

vol. 7 no. 5 384-386
DOI: 
https://doi.org/10.1212/CPJ.0000000000000305
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received July 6, 2016
  • Accepted August 16, 2016
  • First Published September 14, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Swetha Renati, MD,
    2. Supreet Kaur, MD,
    3. Jesse L. Kresak, MD,
    4. Meredith Wicklund, MD and
    5. Irene Malaty, MD
  1. Swetha Renati, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Supreet Kaur, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Jesse L. Kresak, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Meredith Wicklund, MD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) Florida Department of Health Ed and Ethel Moore Alzheimer?s Disease Research Program, grant #6AZ07, Principal Investigator,2016-2018 2) Florida Department of Health Ed and Ethel Moore Alzheimer?s Disease Research Program, grant # 6AZ10 and 6AZ15;, co-investigator, 2016-2018 2)Florida Department of Health Ed and Ethel Moore Alzheimer?s Disease Research Program, grant #5AZ01, 5AZ02, and 5AZ03; co-investigator, 2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Irene Malaty, MD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. Speaker reimbursement or stipend: National Parkinson Foundation, Tourette Association of America

    Funding for travel or speaker honoraria:

    1. (1) National Parkinson Foundation- received travel compensation for attending meetings (2) Tourette syndrome association- received honoraria and travel compensation for speaking (3) American Speech-Language-Hearing Association- I will receive honoraria for speaking

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1)Abbott/ AbbVie- SubInvestigator in research funded by (University of Florida receives funding for research participation) (2)Auspex- Site Primary Investigator in research funded by (University of Florida receives funding for research participation) (3)Biotie- Site Primary Investigator in research funded by (University of Florida receives funding for research participation) (4)Merz- Site Primary Investigator in research funded by (University of Florida receives funding for research participation) (5)Neurocrine- Site Primary Investigator in research funded by (University of Florida receives funding for research participation) (6)Pfizer- Site Primary Investigator in research funded by (University of Florida receives funding for research participation) (7) Revance- Sub-Investigator in research funded by (University of Florida receives funding for research participation) (8) Teva- Site Primary Investigator in research funded by (University of Florida receives funding for research participation)

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1)National Parkinson Foundation- medical directer of Center of Excellence at UF, participant in Quality Improvement Initiative (2)Tourette Syndrome Association- medical advisory board (unpaid); participant in research funded by TSA for which UF received funding (3)Dystonia coalition

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Departments of Neurology (SR, SK, MW, IM) and Pathology (JLK), University of Florida, Gainesville.
  1. Correspondence to:
    Swetha.renati{at}neurology.ufl.edu
View Full Text

Article usage

Article usage: September 2016 to April 2023

AbstractFullPdfSource
Sep 20169504Highwire
Oct 201616305Highwire
Nov 20162600Highwire
Dec 20162501Highwire
Jan 20172000Highwire
Feb 20171000Highwire
Mar 20171600Highwire
Apr 20172400Highwire
May 20171100Highwire
Jun 20171903Highwire
Jul 20172901Highwire
Aug 20171600Highwire
Sep 2017700Highwire
Oct 2017224910Highwire
Nov 2017528610Highwire
Dec 201712993Highwire
Jan 20185233Highwire
Feb 20184720Highwire
Mar 20183431Highwire
Apr 20184722Highwire
May 20184910Highwire
Jun 20182723Highwire
Jul 20183201Highwire
Aug 20183230Highwire
Sep 20181512Highwire
Oct 20182811Highwire
Nov 20183610Highwire
Dec 20184000Highwire
Jan 20192300Highwire
Feb 20192410Highwire
Mar 20191800Highwire
Apr 20191642Highwire
May 20192000Highwire
Jun 20191500Highwire
Jul 20191500Highwire
Aug 20191000Highwire
Sep 20191200Highwire
Oct 20192002Highwire
Nov 20191700Highwire
Dec 20191810Highwire
Jan 20202800Highwire
Feb 20202301Highwire
Mar 20204400Highwire
Apr 20201100Highwire
May 20202300Highwire
Jun 20201100Highwire
Jul 20201300Highwire
Aug 20201611Highwire
Sep 20202411Highwire
Oct 20203500Highwire
Nov 20205500Highwire
Dec 20202001Highwire
Jan 20211510Highwire
Feb 20211711Highwire
Mar 20212200Highwire
Apr 20211300Highwire
May 20212600Highwire
Jun 2021900Highwire
Jul 20212820Highwire
Aug 20212600Highwire
Sep 20211500Highwire
Oct 20211600Highwire
Nov 20212300Highwire
Dec 20211101Highwire
Jan 20222400Highwire
Feb 20221500Highwire
Mar 20221600Highwire
Apr 20222001Highwire
May 20221301Highwire
Jun 2022901Highwire
Jul 2022501Highwire
Aug 2022800Highwire
Sep 20222300Highwire
Oct 20222000Highwire
Nov 20224000Highwire
Dec 20221900Highwire
Jan 20231800Highwire
Feb 20231300Highwire
Mar 20231400Highwire
Apr 20231100Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles